Baldessarini R J
Arch Gen Psychiatry. 1975 Sep;32(9):1087-93. doi: 10.1001/archpsyc.1975.01760270019001.
A leading hypothesis concerning a biological basis of the affective disorders is that altered metabolism of brain amines may underlie the cause or pathophysiology of these conditions. Features of affective illnesses supporting biological hypotheses include the somatic symptoms, diurnal rhythm, and apparent "endogenicity" of many severe depressions, and evidence of a genetic basis of manic-depressive illness. Development and preclinical study of medical therapies for the disorders substantially supported a relationship between mood-disturbances and neutrotransmitters and stimulated considerable advances in the physiology and pharmacology of central synaptic neurotransmission. Unfortunately, studies of amine metabolism in patients have not provided consistent support for the amine hypotheses. Moreover, these hypotheses have not led to a coherent biological theory of abnormal behavior, to an objective basis for differential diagnosis, or to the rational development of treatments more effective or safer than those known.
关于情感障碍生物学基础的一个主要假说是,脑胺代谢改变可能是这些疾病病因或病理生理学的基础。支持生物学假说的情感疾病特征包括躯体症状、昼夜节律以及许多严重抑郁症明显的“内源性”,还有双相情感障碍存在遗传基础的证据。针对这些疾病的医学疗法的研发和临床前研究在很大程度上支持了情绪障碍与神经递质之间的关系,并推动了中枢突触神经传递生理学和药理学的显著进展。不幸的是,对患者胺代谢的研究并未为胺假说提供一致的支持。此外,这些假说尚未形成关于异常行为的连贯生物学理论,也未形成鉴别诊断的客观依据,或导致比已知治疗方法更有效或更安全的治疗方法的合理开发。